Glaukos Corp. (GKOS)
112.10
-3.27
(-2.83%)
USD |
NYSE |
Mar 05, 16:00
112.13
+0.03
(+0.03%)
After-Hours: 20:00
Glaukos Cash from Investing (Quarterly) : -15.89M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -512.00M |
| Intuitive Surgical, Inc. | -209.40M |
| ResMed, Inc. | -50.94M |
| Globus Medical, Inc. | -111.45M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.843M |
| Cash from Financing (Quarterly) | 2.427M |
| Free Cash Flow | -39.06M |
| Free Cash Flow Per Share (Quarterly) | -0.2205 |
| Free Cash Flow to Equity (Quarterly) | -14.91M |
| Free Cash Flow to Firm (Quarterly) | -11.58M |
| Free Cash Flow Yield | -0.61% |